These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3547830)

  • 21. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC; Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
    Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
    Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction of specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor major histocompatibility complex class I antigens.
    Oluwole SF; Chowdhury NC; Fawwaz R; James T; Hardy MA
    Transplant Proc; 1993 Feb; 25(1 Pt 1):299-300. PubMed ID: 8438308
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of anti-interleukin 2 monoclonal antibody treatment on the survival of rat cardiac allograft.
    Sakagami K; Ohsaki T; Ohnishi T; Saito S; Matsuoka J; Orita K
    J Surg Res; 1989 Mar; 46(3):262-6. PubMed ID: 2646474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of portal venous tolerance on the survival of small bowel allografts in the rat.
    Nakafusa Y; Goss JA; Roland CR; Flye MW
    Transplantation; 1993 Nov; 56(5):1279-82. PubMed ID: 8249139
    [No Abstract]   [Full Text] [Related]  

  • 28. Chlorambucil-carrying ALG as an immunosuppressive agent in the rat.
    Papachristou D; Zaki AF; Fortner JG
    Transplant Proc; 1977 Mar; 9(1):1059-62. PubMed ID: 325732
    [No Abstract]   [Full Text] [Related]  

  • 29. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract]   [Full Text] [Related]  

  • 31. Monoclonal anti-IL-2 receptor antibody in primate renal transplantation.
    Shapiro ME; Kirkman RL; Reed MH; Puskas JD; Mazoujian G; Letvin NL; Carpenter CB; Milford EL; Waldmann TA; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):594-8. PubMed ID: 3103282
    [No Abstract]   [Full Text] [Related]  

  • 32. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K
    Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional blocking of the interleukin-2 receptor (IL-2R) may be important in the efficacy of IL-2R antibody therapy.
    Tellides G; Dallman MJ; Kupiec-Weglinski JW; Diamantstein T; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):4231-3. PubMed ID: 3118538
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of mono and combination therapy with FTY720 and ICAM-1 mAb for mouse-to-rat cardiac xenotransplantation].
    Xiong HB; Huang ZF; Ye QF; Xia SS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):41-6. PubMed ID: 17344585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of combined anti-gamma interferon antibody and cyclosporine therapy on cardiac allograft survival in the rat.
    Didlake RH; Kim EK; Sheehan K; Schreiber RD; Kahan BD
    Transplantation; 1988 Jan; 45(1):222-3. PubMed ID: 3122384
    [No Abstract]   [Full Text] [Related]  

  • 36. Transforming growth factor-beta/interleukin-2-induced regulatory CD4+ T cells prolong cardiac allograft survival in rats.
    Watanabe M; Mencel RL; Cramer DV; Starnes VA; Barr ML
    J Heart Lung Transplant; 2005 Dec; 24(12):2153-9. PubMed ID: 16364865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H; Hara MH; Miyahara T; Tanigawa M; Matsuzaki Y; Onitsuka T; Shibata K; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Iwaya M; Miyasaka M; Kimura H
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract]   [Full Text] [Related]  

  • 38. Xenogeneic (rat to mouse) skin tolerance induced by monoclonal antibodies, xenogeneic cells, and cyclophosphamide.
    Umesue M; Mayumi H; Nishimura Y; Kong YY; Omoto K; Murakami Y; Nomoto K; Nomoto K
    Transplant Proc; 1995 Feb; 27(1):315-6. PubMed ID: 7879018
    [No Abstract]   [Full Text] [Related]  

  • 39. Persistent infiltration of CD45RC- CD4+ T cells, Th2-like effector cells, in prolonging hepatic allografts in rats pretreated with a donor-specific blood transfusion.
    Miyanari N; Yamaguchi Y; Matsuno K; Tominaga A; Goto M; Ichiguchi O; Mori K; Ogawa M
    Hepatology; 1997 Apr; 25(4):1008-13. PubMed ID: 9096612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance to cardiac allografts induced in utero with fetal liver cells.
    Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
    Circulation; 1996 Nov; 94(9 Suppl):II304-7. PubMed ID: 8901765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.